Thank you!

👏Many congratulations👏 to Professor Sadaf Farooqi
@farooqi-lab.bsky.social for being honoured with the prestigious Gerald D Aurbach Award by the Endocrine Society
for Outstanding Translational Research
More👉 bit.ly/46gFx1d
@ims-mrl.bsky.social @cuh.nhs.uk @cam.ac.uk @endocrinesociety.bsky.social

Thank you to the @endocrinesociety.bsky.social for this prestigious honour!

Thank you!

🙌Many congratulations to all winners, but in particular our very own Professor Sadaf Farooqi as recipient of the Gerald D. Aurbach Award for Outstanding Translational Research.

ℹ️https://www.mrl.ims.cam.ac.uk/news/professor-sadaf-farooqi-honoured-endocrine-society-2026-laureate-award

Professor Farooqi to receive 2026 Laureate Award from @endocrinesociety.bsky.social!
Details on Endocrine Society website and here:
www.goos.org.uk/resource-cen...

#4
With thanks to our collaborators and funders @cambridgebrc.bsky.social @wellcometrust.bsky.social @tesscacciottolo.bsky.social

#3
And the benefits of GCGR agonists which reduce liver fat in people with obesity and MASLD.
@rarediseaseuk (on X) @CamMetaboNet (on X) @ims-mrl.bsky.social

#2
Results are relevant for understanding the risks associated with GCGR antagonists which have been trialled in people with type 2 diabetes.

#1
In a paper just published online in Diabetes, we showed that homozygous loss-of-function mutations in the Glucagon receptor (GCGR) cause early-onset hepatic steatosis in people.
DOI: doi.org/10.2337/db25...